Part of the Physical Sciences and Mathematics Commons

Works by Karl E. Peace in Physical Sciences and Mathematics

2023

Statistical Analytics for Health Data Science with SAS and R, Jeffrey Wilson, Ding-Geng Chen, Karl E. Peace
Karl E. Peace

COVID-19 Pandemic in Brazil: Clinical Manifestation and Effect of Comorbidities on Outcomes of Hospitalized SARI Cases, Mario Keko, Karl E. Peace
Karl E. Peace

The Pharmaceutical Industry Contributes to Public Health, Karl E. Peace, Mario Keko
Karl E. Peace

COVID-19 Pandemic in Brazil: Clinical Manifestation and Effect of Comorbidities on Outcomes of Hospitalized SARI Cases, Mario Keko, Karl E. Peace
Karl E. Peace

COVID-19 Pandemic in Brazil: Clinical manifestation and effect of comorbidities on outcomes of hospitalized SARI cases, Mario Keko, Karl E. Peace
Karl E. Peace

Statistical Analytics for Health Data Science with SAS and R, Jeffrey Wilson, Ding-Geng Chen, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Bookshelf

2022

COVID-19 Pandemic in Brazil: Clinical manifestation and effect of comorbidities on outcomes of hospitalized SARI cases, Mario Keko, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Presentations

2021

40 Years of the Biopharmaceutical Section: Celebrating our Past, Planning for our Future, Charles Buncher, Stacy Lindborg, Karl E. Peace, Matilde Sanchez-Kam, Steve Wilson
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Presentations

Informatics and the Covid-19 Crisis: the Role of Information Systems and Clinical Trials Databases, Gulzar H. Shah, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Unplanned Changes in Estimands with Two-Stage Adaptive Designs, Qing Liu, Karl E. Peace
Karl E. Peace

Commentary: Is Informed Consent as Ethical as it Could be?, Karl E. Peace
Karl E. Peace

Applied Meta-Analysis with R and Stata, Ding-Geng Chen, Karl E. Peace
Karl E. Peace

Is Informed Consent as Ethical as It Could Be?, Karl E. Peace
Karl E. Peace

Fruits and Labors of a Purpose Driven Life, Karl E. Peace
Karl E. Peace

Interval-Censoring in Biomedical and Biopharmaceutical Clinical Trials, Ding-Geng Chen, Karl E. Peace, Lili Yu, Y. L. Lio, Yibin Wang
Karl E. Peace

Peace named Statesboro Herald Humanitarian of the Year: Deen Day Smith recipient 'a true public health hero', Karl E. Peace
Karl E. Peace

Filling Gaps: Karl Peace Meets Needs with his Time, Talent and Treasure, Karl E. Peace
Karl E. Peace

A Conversation with Karl E. Peace, Karl E. Peace
Karl E. Peace

Extraordinary Journey, Karl E. Peace
Karl E. Peace

Peace Honored with Regents’ Hall of Fame Award, Karl E. Peace
Karl E. Peace

Philanthropy Advances Georgia Southern’s Development, Karl E. Peace
Karl E. Peace

Statistics Profession Honors Karl E. Peace, Karl E. Peace
Karl E. Peace

Sellers-McCroan Award Presented to Dr. Karl Peace, Karl E. Peace
Karl E. Peace

Ron Brookmeyer 2016 Recipient of ASA Karl E. Peace Award for contributions toward betterment of Society, Karl E. Peace
Karl E. Peace

James Cochran 2015 Recipient of ASA Karl E. Peace Award for contributions toward betterment of Society, Karl E. Peace
Karl E. Peace

Richard Simon 2013 Recipient of ASA Karl E. Peace Award for contributions toward betterment of Society, Karl E. Peace
Karl E. Peace

Marvin Zelen First Recipient of ASA Karl E. Peace Award for contributions toward betterment of Society, Karl E. Peace
Karl E. Peace

Mitchell Gail 2017 Recipient of ASA Karl E. Peace Award for contributions toward betterment of Society, Karl E. Peace
Karl E. Peace

Gary Koch 2014 Recipient of ASA Karl E. Peace Award for contributions toward betterment of Society, Karl E. Peace
Karl E. Peace

Bulloch County’s (no longer) Secret Advantage, Karl E. Peace
Karl E. Peace

Master of Adversity: Overcoming long odds, Karl E. Peace was pivotal in JPHCOPH founding, Karl E. Peace
Karl E. Peace

Karl E. Peace – a Friend to the Biostatistics Community, Karl E. Peace
Karl E. Peace

Karl Peace Honored with Painting, Karl E. Peace
Karl E. Peace

Improve Membership in the APHA Statistics Section, Karl E. Peace
Karl E. Peace

Foreword by Karl E. Peace, Karl E. Peace
Karl E. Peace

Applied Meta-analysis using R and STATA, 2nd Edition, Ding-Geng Chen, Karl E. Peace
Karl E. Peace

Approval of Drugs in the US – Hitting close to Home, Karl E. Peace
Karl E. Peace

ASU Graduate Symposium to feature distinguished cancer scholar, Karl E. Peace
Karl E. Peace

Approval of Drugs in the USA, Karl E. Peace
Karl E. Peace

Kings of the road: A driving passion for classic car collectors, Karl E. Peace
Karl E. Peace

Every Person must Decide, Karl E. Peace
Karl E. Peace

Letter to the Editor, Re: Make a Plan and Follow it, Karl E. Peace
Karl E. Peace

Does Public Health Matter?, Charles J. Hardy, Karl E. Peace
Karl E. Peace

Contributions of Karl Peace recognized by the U.S. Congress, Karl E. Peace
Karl E. Peace

Public Health Classroom, J. Grillo, Karl E. Peace
Karl E. Peace

The Pharmaceutical Industry as a Major Player in Public Health, Karl E. Peace
Karl E. Peace

Sowing what you Reap, Karl E. Peace
Karl E. Peace

The Man from Alligator Creek, Karl E. Peace
Karl E. Peace

Informatics and the Covid-19 Crisis: the Role of Information Systems and Clinical Trials Databases, Gulzar H. Shah, Karl E. Peace
Gulzar H. Shah Dr.

A Serious Flaw in Nutrition Epidemiology: A Meta-Analysis Study, Karl E. Peace, Jingjing Yin, Haresh Rochani, Sarbesh R. Pandeya, Stanley Young
Haresh Rochani

The Pharmaceutical Industry Contributes to Public Health, Karl E. Peace, Mario Keko
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Applied Meta-analysis using R and STATA, 2nd Edition, Ding-Geng Chen, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Bookshelf

COVID-19 Pandemic in Brazil: Clinical Manifestation and Effect of Comorbidities on Outcomes of Hospitalized SARI Cases, Mario Keko, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

PDF

COVID-19 Pandemic in Brazil: Clinical Manifestation and Effect of Comorbidities on Outcomes of Hospitalized SARI Cases, Mario Keko, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

2020

Approximating the Baseline Hazard Function by Taylor Series for Interval-Censored Time-to-Event Data, Ding-Geng Chen, Lili Yu, Karl E. Peace, Y. L. Lio, Yibin Wang
Lili Yu

Spline Nonparametric Quasi-Likelihood Regression Within the Frame of the Accelerated Failure Time Model, Lili Yu, Karl E. Peace
Lili Yu

Bias and its Remedy in Interval Censored Time-to-Event Applications, Ding-Geng Chen, Lili Yu, Karl E. Peace, Jianguo Sun
Lili Yu

Interval-Censoring in Biomedical and Biopharmaceutical Clinical Trials, Ding-Geng Chen, Karl E. Peace, Lili Yu, Y. L. Lio, Yibin Wang
Lili Yu

Interval-Censoring in Biomedical and Biopharmaceutical Clinical Trials, Ding-Geng Chen, Karl E. Peace, Lili Yu, Y. L. Lio, Yibin Wang
Lili Yu

A Comparison of Two Methods for Generating Data That Follow The Lindley Distribution, Macaulay Okwuokenye, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Background, Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands, Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands (Part III), Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands (Part I), Qing Liu, Karl E. Peace
Karl E. Peace

A Serious Flaw in Nutrition Epidemiology: A Meta-Analysis Study, Karl E. Peace, Jingjing Yin, Haresh Rochani, Sarbesh R. Pandeya, Stanley Young
Karl E. Peace

A Survival Analysis Instead of an Endpoint Analysis for Antibiotic Data, Karl E. Peace
Karl E. Peace

Applied Meta-Analysis with R, Ding-Geng Chen, Karl E. Peace
Karl E. Peace

Approximating the Baseline Hazard Function by Taylor Series for Interval-Censored Time-to-Event Data, Ding-Geng Chen, Lili Yu, Karl E. Peace, Y. L. Lio, Yibin Wang
Karl E. Peace

Assessing the Validity of Statistical Inferences in Public Health Research: An Evidence-Based, "Best Practices" Approach, Karl E. Peace, Anthony V. Parrillo, Charlie J. Hardy
Karl E. Peace

Regression Multiple Imputation for Missing Data Analysis, Lili Yu, Liang Liu, Karl E. Peace
Lili Yu

Statistical Considerations for Clinical Trials During COVID-19: An Adaptive Hybrid Design for Clinical Development in Rare Diseases, Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Analysis Methods for Providing Inferences between Primary Response Measures and Exposure to Study Medication, Karl E. Peace, H. C. Carter
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: A Two-Stage Adaptive Design for Clinical Trials in Patients with COVID-19 High Risks, Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Accurate COVID-19 Testing in Clinical Trials, Stephan Ogenstad, Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands (Part II), Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: A Two-Stage Adaptive Design for Clinical Trials with Chronic Conditions, Qing Liu, Karl E. Peace
Karl E. Peace

Adaptive Design and the Estimand Framework, Macaulay Okwuokenye, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment, Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part II), Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part III), Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Impacts on Minimization Randomization and Mitigations, Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part I), Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Impacts on Permuted Block Randomization and Mitigations, Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Independent DMC for Blinded Data Monitoring and Analysis, Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Integrated Analysis of Efficacy (IAE) with Adaptive Estimands, Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Interim Analysis with Adaptive Estimands Based, Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Natural History Controls for Survival Analysis, Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Natural History Controls for Survival Analysis (Part I), Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Natural History Controls for Survival Analysis (Part III), Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Natural History Controls for Survival Analysis (Part II), Qing Liu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Phase 1 Cancer Trials, Michael T. Tirgan, Qing Liu, Karl E. Peace
Karl E. Peace

Clinical Trial Methodology, Karl E. Peace, Ding-Geng Chen
Karl E. Peace

Design and Analysis of Clinical Trials with Time to Event Endpoints, Karl E. Peace
Karl E. Peace

Paid In Full, Karl E. Peace
Karl E. Peace

Bias and its Remedy in Interval Censored Time-to-Event Applications, Ding-Geng Chen, Lili Yu, Karl E. Peace, Jianguo Sun
Karl E. Peace

Case Study in Optimal Dosing in Duodenal Ulcer, Karl E. Peace
Karl E. Peace

Regression Multiple Imputation for Missing Data Analysis, Lili Yu, Liang Liu, Karl E. Peace
Karl E. Peace

Fixed Combination Drug Development and the Need for Placebo, Karl E. Peace
Karl E. Peace

Biostatistical Aspects of the Development of Drugs to Prevent NSAID Induced Gastric Ulcers, Karl E. Peace
Karl E. Peace

Equilibrium-Based Bipolar Neurological Modeling, Wen-Ran Zhang, Anand K. Pandurangi, Karl E. Peace
Karl E. Peace

Clinical Trials: Location Matters, Karl E. Peace
Karl E. Peace

Bivariate or Composite Plots of Endpoints, Karl E. Peace, Kao-Tai Tsai
Karl E. Peace

Clinically Optimal Dosing in the Treatment of Duodenal Ulcers: A Case Study of a Phase III SNDA Clinical Program, Karl E. Peace
Karl E. Peace

Interval-Censoring in Biomedical and Biopharmaceutical Clinical Trials, Ding-Geng Chen, Karl E. Peace, Lili Yu, Y. L. Lio, Yibin Wang
Karl E. Peace

Is Informed Consent as Ethical as It Could Be?, Karl E. Peace
Karl E. Peace

Joint Modeling of the Treatment Effect in Clinical Trials with Time-to-Event Endpoint and Safety Covariates, Kao-Tai Tsai, Karl E. Peace
Karl E. Peace

MentalSquares − A Generic Bipolar Support Vector Machine for Mental Disorder Classification, Diagnostic Analysis, and Neurobiological Data Mining, Wen-Rang Zhang, Anand K. Pandurangi, Karl E. Peace, Yan-Qing Zhang
Karl E. Peace

Making Informed Consent More Ethical, Karl E. Peace
Karl E. Peace

Monitoring Adverse Experiences in Clinical Drug Development, Karl E. Peace
Karl E. Peace

Multivariate Dose Response Test, Kao-Tai Tsai, Karl E. Peace
Karl E. Peace

On Truth, Uncertainity, Equilibrium and Harmony — A Taxonomy for YinYang Scientific Computing, Wen-Ran Zhang, Paul P. Wang, Karl E. Peace, Justin Zhan, Yan-Qing Yan-Qing Zhang
Karl E. Peace

On the Analysis of a Combination of Two Primary Efficacy Measures, Karl E. Peace
Karl E. Peace

Safety of Drugs is, Indeed, a Lifecycle Exercise, Karl E. Peace
Karl E. Peace

Racial Differences in Perception of Breast Cancer Risk in Rural Southeast Georgia, Stuart Tedders, Anthony V. Parrillo, Karl E. Peace, Jannell R. Knight
Karl E. Peace

Sample Sizes in the Clinical Development Plan Premarket Approval, Karl E. Peace
Karl E. Peace

Spline Nonparametric Quasi-Likelihood Regression Within the Frame of the Accelerated Failure Time Model, Lili Yu, Karl E. Peace
Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Steps for Mitigation, Qing Liu, Karl E. Peace
Karl E. Peace

The Design and Analysis of Pivotal Proof of Efficacy Trials in the Development of Drugs to Treat Panic Disorder, Karl E. Peace
Karl E. Peace

The Importance of the Question Relative to Statistical Analysis in Medical Research, Karl E. Peace
Karl E. Peace

The Statistical Section of a Clinical Protocol, Karl E. Peace
Karl E. Peace

Toward a New Standard for Classification and Analysis of Bipolar Disorders with Mixed States, Wen-Rang Zhang, Karl E. Peace, Anand K. Pandurangi
Karl E. Peace

The Validity of Statistical Inference, Karl E. Peace
Karl E. Peace

Yin Yang Mental Squares - An Equilibrium-Based System for Bipolar Neurobiological Pattern Classification and Analysis, Wen-Ran Zhang, Karl E. Peace
Karl E. Peace

YinYang Dynamic Neurobioological Modeling and Diagnostic Analysis of Major Depressive and Bipolar Disorders, Wen-Rang Zhang, Anand K. Pandurangi, Karl E. Peace
Karl E. Peace

Efficacy of Delayed-Release Dimethyl Fumarate vs Glatiramer Acetate on a Novel Composite Outcome Measure of Inflammatory Disease Activity: Post-Hoc Analysis of the CONFIRM Study, M. Kremenchutzky, R. J. Fox, J. T. Phillips, Mariko Kita, Karl E. Peace, J. B. Lewin, A. Zhang, M Okwuokenye, M Edwards, J Marantz
Karl E. Peace

Rates of Chlamydia, Gonorhea and Genital Herpes before and after Spring Break and Homecoming at an American Southeastern University, Macaulay Okwuokenye, Karl E. Peace, E. Deloach, G. Shah
Karl E. Peace

Closest Similar Subset Imputation for Missing Data Analysis, Macaulay Okwuokenye, Karl E. Peace
Karl E. Peace

Informatics and the Covid-19 Crisis: the Role of Information Systems and Clinical Trials Databases, Gulzar H. Shah, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Impacts on Minimization Randomization and Mitigations, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part I), Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part II), Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part III), Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands (Part II), Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Steps for Mitigation, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Regression Multiple Imputation for Missing Data Analysis, Lili Yu, Liang Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Integrated Analysis of Efficacy (IAE) with Adaptive Estimands, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Interim Analysis with Adaptive Estimands Based, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: An Adaptive Hybrid Design for Clinical Development in Rare Diseases, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: A Two-Stage Adaptive Design for Clinical Trials with Chronic Conditions, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Natural History Controls for Survival Analysis (Part I), Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Natural History Controls for Survival Analysis (Part II), Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Natural History Controls for Survival Analysis (Part III), Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: A Two-Stage Adaptive Design for Clinical Trials in Patients with COVID-19 High Risks, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands (Part III), Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Natural History Controls for Survival Analysis, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Accurate COVID-19 Testing in Clinical Trials, Stephan Ogenstad, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Phase 1 Cancer Trials, Michael T. Tirgan, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Independent DMC for Blinded Data Monitoring and Analysis, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Impacts on Permuted Block Randomization and Mitigations, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

A Serious Flaw in Nutrition Epidemiology: A Meta-Analysis Study, Karl E. Peace, Jingjing Yin, Haresh Rochani, Sarbesh R. Pandeya, Stanley Young
Jingjing Yin

Statistical Considerations for Clinical Trials During COVID-19: Background, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands (Part I), Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Statistical Considerations for Clinical Trials During COVID-19: Unplanned Changes in Estimands with Two-Stage Adaptive Designs, Qing Liu, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

2019

Closest Similar Subset Imputation for Missing Data Analysis, Macaulay Okwuokenye, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Adaptive Design and the Estimand Framework, Macaulay Okwuokenye, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

2018

Assessment of Drug Safety, Karl E. Peace
Karl E. Peace

Number Needed to Treat in Multiple Sclerosis Clinical Trials, Macaulay Okwuokenye, Annie Zhang, Amy Pace, Karl E. Peace
Karl E. Peace

Efficacy of Delayed-Release Dimethyl Fumarate vs Glatiramer Acetate on a Novel Composite Outcome Measure of Inflammatory Disease Activity: Post-Hoc Analysis of the CONFIRM Study, Marcelo Kremenchutzky, Robert J. Fox, J. Theodore Phillips, Mariko Kita, Karl E. Peace, James B. Lewin, Annie Zhang, Macaulay Okwuokenye, Michael R. Edwards, Jing L. Marantz
Karl E. Peace

Multivariate Dose-Response Analysis of Ordinal Response Data, Kao-Tai Tsai, Karl E. Peace
Karl E. Peace

Adaptive Selection of Counties to Control Versus Intervention Groups in SW Georgia Behavioral Study, Karl E. Peace
Karl E. Peace

Clinical Trial Data Analysis Using R and SAS, Ding-Geng Chen, Karl E. Peace, Pinggao Zhang
Karl E. Peace

Choosing the Function of Baseline Run-In Data for Use as a Covariate in the Analysis of Treatment Data from Phase III Clinical Trials in Hypertension, Yi Hao, Karl E. Peace
Karl E. Peace

Interval-Censored Time-to-Event Data: Methods and Applications, Ding-Geng Chen, Jianguo Sun, Karl E. Peace
Karl E. Peace

Interesting Applications from Three Decades of Biostatistical Consulting, Karl E. Peace, Uche Eseoghene Okoro, Kao-Tai Tsai
Karl E. Peace

Overview of Time-to-Event Endpoint Methodology, Karl E. Peace
Karl E. Peace

Overview of Parametric Based Inferential Methods for Time-to-Event Endpoints, Karl E. Peace, Kao-Tai Tsai
Karl E. Peace

Time-to-Event Endpoint Methods in Antibiotic Trials, Karl E. Peace
Karl E. Peace

On Some Statistical Issues Involving Clinical Trials in Oncology, Karl E. Peace, M. Rothman
Karl E. Peace

Genetic Matching: A Better Algorithm for Adjusting Covariate Imbalance for Statistical Data Analysis and Modeling, Kao-Tai Tsai, Karl E. Peace
Karl E. Peace

A Serious Flaw in Nutrition Epidemiology: A Meta-Analysis Study., Karl E. Peace, Jingjing Yin, Haresh Rochani, Stanley E. Young
Haresh Rochani

Discrete Time-to-Event and Score-Based Methods with Application to Composite Endpoint for Assessing Evidence of Disease Activity-Free, Macaulay Okwuokenye, Karl E. Peace
Karl E. Peace

Whys and Hows of Adverse Event Monitoring, Karl E. Peace
Karl E. Peace

A Serious Flaw in Nutrition Epidemiology: A Meta-Analysis Study, Karl E. Peace, Jingjing Yin, Haresh Rochani, Sarbesh R. Pandeya, Stanley Young
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Interesting Applications from Three Decades of Biostatistical Consulting, Karl E. Peace, Uche Eseoghene Okoro, Kao-Tai Tsai
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Choosing the Function of Baseline Run-In Data for Use as a Covariate in the Analysis of Treatment Data from Phase III Clinical Trials in Hypertension, Yi Hao, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

2017

Racial Differences in Perception of Breast Cancer Risk in Rural Southeast Georgia, Stuart Tedders, Anthony V. Parrillo, Karl E. Peace, Jannell R. Knight
Stuart H. Tedders

Number Needed to Treat in Multiple Sclerosis Clinical Trials, Macaulay Okwuokenye, Annie Zhang, Amy Pace, Karl E. Peace
Biostatistics Faculty Publications

Clinical Trial Data Analysis Using R and SAS, Ding-Geng Chen, Karl E. Peace, Pinggao Zhang
Biostatistics Faculty Bookshelf

Peace named Statesboro Herald Humanitarian of the Year: Deen Day Smith recipient 'a true public health hero', Karl E. Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews

YinYang Bipolar Dynamic Organizational Modeling for Equilibrium-Based Decision Analysis: Logical Transformation of an Indigenous Philosophy to a Global Science, Wen-Ran Zhang, Karl E. Peace, Hyo-Joo Han
Wen-Ran Zhang

YinYang Bipolar Dynamic Organizational Modeling for Equilibrium-Based Decision Analysis: Logical Transformation of an Indigenous Philosophy to a Global Science, Wen-Ran Zhang, Karl E. Peace, Hyo-Joo Han
Karl E. Peace

YinYang Bipolar Dynamic Organizational Modeling for Equilibrium-Based Decision Analysis: Logical Transformation of an Indigenous Philosophy to a Global Science, Wen-Ran Zhang, Karl E. Peace, Hyo-Joo Han
Hyo-Joo Han

Mitchell Gail 2017 Recipient of ASA Karl E. Peace Award for contributions toward betterment of Society, Karl E. Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews

2016

Monitoring for Adverse Events Post Marketing Approval of Drugs, Karl E. Peace, Macaulay Okwuokenye
Karl E. Peace

A SASR Algorithm for Imputing Discrete Missing Outcomes Based on Minimum Distance, Macaulay Okwuokenye, Karl E. Peace
Karl E. Peace

Inequalities and Approximations of Weighted Distributions by Lindley Reliability Measures, and the Lindley-Cox Model with Applications, Broderick O. Oluyede, Macaulay Okwuokenye, Karl E. Peace
Broderick O. Oluyede

YinYang Bipolar Dynamic Organizational Modeling for Equilibrium-Based Decision Analysis: Logical Transformation of an Indigenous Philosophy to a Global Science, Wen-Ran Zhang, Karl E. Peace, Hyo-Joo Han
Department of Computer Science Faculty Publications

Whys and Hows of Adverse Event Monitoring, Karl E. Peace
Biostatistics Faculty Presentations

A Comparison of Size and Power of Tests of Hypotheses on Parameters Based on Two Generalized Lindley Distributions, Macaulay Okwuokenye, Karl E. Peace
Karl E. Peace

A Comparison of Size and Power of Tests of Hypotheses on Parameters Based on Two Generalized Lindley Distributions, Macaulay Okwuokenye, Karl E. Peace
Karl E. Peace

A Comparison of Size and Power of Tests of Hypotheses on Parameters Based on Two Generalized Lindley Distributions, Macaulay Okwuokenye, Karl E. Peace
Karl E. Peace

Size and Power of Tests of Hypotheses on Survival Parameters from the Lindley Distribution with Covariates, Macaulay Okwuokenye, Karl E. Peace
Karl E. Peace

Size and Power of Tests of Hypotheses on Survival Parameters from the Lindley Distribution with Covariates, Macaulay Okwuokenye, Karl E. Peace
Karl E. Peace

Equilibrium-Based Bipolar Neurological Modeling, Wen-Ran Zhang, Anand K. Pandurangi, Karl E. Peace
Wen-Ran Zhang

On Truth, Uncertainity, Equilibrium and Harmony — A Taxonomy for YinYang Scientific Computing, Wen-Ran Zhang, Paul P. Wang, Karl E. Peace, Justin Zhan, Yan-Qing Yan-Qing Zhang
Wen-Ran Zhang

Yin Yang Mental Squares - An Equilibrium-Based System for Bipolar Neurobiological Pattern Classification and Analysis, Wen-Ran Zhang, Karl E. Peace
Wen-Ran Zhang

Toward a New Standard for Classification and Analysis of Bipolar Disorders with Mixed States, Wen-Rang Zhang, Karl E. Peace, Anand K. Pandurangi
Wen-Ran Zhang

Revealing the Ubiquitous Effects of Quantum Entanglement-Toward a Notion of God Logic, Wen-Ran Zhang, Karl E. Peace
Wen-Ran Zhang

YinYang Dynamic Neurobioological Modeling and Diagnostic Analysis of Major Depressive and Bipolar Disorders, Wen-Rang Zhang, Anand K. Pandurangi, Karl E. Peace
Wen-Ran Zhang

Ron Brookmeyer 2016 Recipient of ASA Karl E. Peace Award for contributions toward betterment of Society, Karl E. Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews

A Conversation with Karl E. Peace, Karl E. Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews

Modeling the Probability of Second Cancers in Controlled Clinical Trials, Kao-Tai Tsai, Karl E. Peace
Karl E. Peace

2015

MentalSquares − A Generic Bipolar Support Vector Machine for Mental Disorder Classification, Diagnostic Analysis, and Neurobiological Data Mining, Wen-Rang Zhang, Anand K. Pandurangi, Karl E. Peace, Yan-Qing Zhang
Wen-Ran Zhang

MentalSquares: A Generic Bipolar Support Vector Machine for Psychiatric Disorder Classification, Diagnostic Analysis and Neurological Data Mining, Wen-Ran Zhang, Anand K. Pandurangi, Karl E. Peace, Yan-Qing Zhang, Zhongming Zhao
Wen-Ran Zhang

Causality Is Logically Definable-Toward an Equilibrium-Based Computing Paradigm of Quantum Agents and Quantum Intelligence (QAQI), Wen-Ran Zhang, Karl E. Peace
Wen-Ran Zhang

Discrete Time-to-Event and Score-Based Methods with Application to Composite Endpoint for Assessing Evidence of Disease Activity-Free, Macaulay Okwuokenye, Karl E. Peace
Biostatistics Faculty Presentations

Size and Power of Tests of Hypotheses on Survival Parameters from the Lindley Distribution with Covariates, Macaulay Okwuokenye, Karl E. Peace
Karl E. Peace

Inequalities and Approximations of Weighted Distributions by Lindley Reliability Measures, and the Lindley-Cox Model with Applications, Broderick O. Oluyede, Macaulay Okwuokenye, Karl E. Peace
Karl E. Peace

Joint Modeling of Treatment Effect on Time-to-Event Endpoint and Safety Covariates in Control Clinical Trial Data Analysis, Kao-Tai Tsai, Karl E. Peace
Karl E. Peace

A Comparison of Size and Power of Tests of Hypotheses on Parameters Based on Two Generalized Lindley Distributions, Macaulay Okuokenye, Karl E. Peace
Karl E. Peace

Monitoring for Adverse Events Post Marketing Approval of Drugs, Karl E. Peace, Macaulay Okwuokenye
Biostatistics Faculty Publications

PDF

Efficacy of Delayed-Release Dimethyl Fumarate vs Glatiramer Acetate on a Novel Composite Outcome Measure of Inflammatory Disease Activity: Post-Hoc Analysis of the CONFIRM Study, Marcelo Kremenchutzky, Robert J. Fox, J. Theodore Phillips, Mariko Kita, Karl E. Peace, James B. Lewin, Annie Zhang, Macaulay Okwuokenye, Michael R. Edwards, Jing L. Marantz
Biostatistics Faculty Publications

Efficacy of Delayed-Release Dimethyl Fumarate vs Glatiramer Acetate on a Novel Composite Outcome Measure of Inflammatory Disease Activity: Post-Hoc Analysis of the CONFIRM Study, M. Kremenchutzky, R. J. Fox, J. T. Phillips, Mariko Kita, Karl E. Peace, J. B. Lewin, A. Zhang, M Okwuokenye, M Edwards, J Marantz
Biostatistics Faculty Presentations

Efficacy of Delayed-Release Dimethyl Fumarate vs Glatiramer Acetate on a Novel Composite Outcome Measure of Inflammatory Disease Activity: Post-Hoc Analysis of the CONFIRM Study, Marcelo Kremenchutzky, Robert J. Fox, J. Theodore Phillips, Mariko Kita, Karl E. Peace, James B. Lewin, Annie Zhang, Macaulay Okwuokenye, Michael R. Edwards, Jing L. Marantz
Karl E. Peace

A SASR Algorithm for Imputing Discrete Missing Outcomes Based on Minimum Distance, Macaulay Okwuokenye, Karl E. Peace
Biostatistics Faculty Publications

Rates of Chlamydia, Gonorrhea, and Genital Herpes Before and After Spring Break and Homecoming at a Southeastern American University, Macaulay Okwuokenye, Karl E. Peace, Brian Deloach, Paul Ferguson, Gulzar H. Shah
Gulzar H. Shah Dr.

Causality Is Logically Definable-Toward an Equilibrium-Based Computing Paradigm of Quantum Agents and Quantum Intelligence (QAQI), Wen-Ran Zhang, Karl E. Peace
Karl E. Peace

Rates of Chlamydia, Gonorrhea, and Genital Herpes Before and After Spring Break and Homecoming at a Southeastern American University, Macaulay Okwuokenye, Karl E. Peace, Brian Deloach, Paul Ferguson, Gulzar H. Shah
Karl E. Peace

Revealing the Ubiquitous Effects of Quantum Entanglement-Toward a Notion of God Logic, Wen-Ran Zhang, Karl E. Peace
Karl E. Peace

Analysis of Subgroup Data of Clinical Trials, Kao-Tai Tsai, Karl E. Peace
Karl E. Peace

Joint Modeling of Treatment Effect on Time-to-Event Endpoint and Safety Covariates in Control Clinical Trial Data Analysis, Kao-Tai Tsai, Karl E. Peace
Biostatistics Faculty Publications

PDF

Size and Power of Tests of Hypotheses on Survival Parameters from the Lindley Distribution with Covariates, Macaulay Okwuokenye, Karl E. Peace
Biostatistics Faculty Publications

PDF

Extraordinary Journey, Karl E. Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews

Fruits and Labors of a Purpose Driven Life, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Presentations

A Comparison of Size and Power of Tests of Hypotheses on Parameters Based on Two Generalized Lindley Distributions, Macaulay Okwuokenye, Karl E. Peace
Biostatistics Faculty Publications

Inequalities and Approximations of Weighted Distributions by Lindley Reliability Measures, and the Lindley-Cox Model with Applications, Broderick O. Oluyede, Macaulay Okwuokenye, Karl E. Peace
Biostatistics Faculty Publications

PDF

James Cochran 2015 Recipient of ASA Karl E. Peace Award for contributions toward betterment of Society, Karl E. Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews

Filling Gaps: Karl Peace Meets Needs with his Time, Talent and Treasure, Karl E. Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews

2014

Modeling the Probability of Second Cancers in Controlled Clinical Trials, Kao-Tai Tsai, Karl E. Peace
Biostatistics Faculty Publications

Rates of Chlamydia, Gonorrhea and Genital Herpes Before and After Spring Break and Homecoming at an American Southeastern University, M. Okuokenye, Karl E. Peace, Brian Deloach, Gulzar H. Shah
Karl E. Peace

Importance of Numbers of Patients in Comparative Clinical Trials, Karl E. Peace, Y. Hao, K. Zerbo, M. Okuokenye
Karl E. Peace

Rates of Chlamydia, Gonorhea and Genital Herpes before and after Spring Break and Homecoming at an American Southeastern University, Macaulay Okwuokenye, Karl E. Peace, E. Deloach, G. Shah
Biostatistics Faculty Presentations

Importance of Placebo in Combination Drug Development, Karl E. Peace, K. Zerbo, Y. Hao, M. Okuokenye
Karl E. Peace

Clinical Trial Research in a Regulatory Setting, Karl E. Peace
Karl E. Peace

Analysis of Subgroup Data in Clinical Trials, Kao-Tai Tsai, Karl E. Peace
Karl E. Peace

Causality Is Logically Definable-Toward an Equilibrium-Based Computing Paradigm of Quantum Agents and Quantum Intelligence (QAQI), Wen-Ran Zhang, Karl E. Peace
Biostatistics Faculty Publications

PDF

Sellers-McCroan Award Presented to Dr. Karl Peace, Karl E. Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews

Gary Koch 2014 Recipient of ASA Karl E. Peace Award for contributions toward betterment of Society, Karl E. Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews

Statistics Profession Honors Karl E. Peace, Karl E. Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews

2013

Revealing the Ubiquitous Effects of Quantum Entanglement-Toward a Notion of God Logic, Wen-Ran Zhang, Karl E. Peace
Biostatistics Faculty Publications

PDF

Analysis of Subgroup Data of Clinical Trials, Kao-Tai Tsai, Karl E. Peace
Biostatistics Faculty Publications

PDF

Approximating the Baseline Hazard Function by Taylor Series for Interval-Censored Time-to-Event Data, Ding-Geng Chen, Lili Yu, Karl E. Peace, Y. L. Lio, Yibin Wang
Karl E. Peace

Applied Meta-Analysis with R, Ding-Geng Chen, Karl E. Peace
Biostatistics Faculty Bookshelf

Rates of Chlamydia, Gonorrhea, and Genital Herpes Before and After Spring Break and Homecoming at a Southeastern American University, Macaulay Okwuokenye, Karl E. Peace, Brian Deloach, Paul Ferguson, Gulzar H. Shah
Biostatistics Faculty Publications

Approximating the Baseline Hazard Function by Taylor Series for Interval-Censored Time-to-Event Data, Ding-Geng Chen, Lili Yu, Karl E. Peace, Y. L. Lio, Yibin Wang
Biostatistics Faculty Publications

Applied Meta-Analysis with R, Ding-Geng Chen, Karl E. Peace
Karl E. Peace

Richard Simon 2013 Recipient of ASA Karl E. Peace Award for contributions toward betterment of Society, Karl E. Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews

Philanthropy Advances Georgia Southern’s Development, Karl E. Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews

2012

A Comparison of Two Methods for Generating Data That Follow The Lindley Distribution, Macaulay Okwuokenye, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Clinical Trial Methodology, Karl E. Peace
Karl E. Peace

Spline Nonparametric Quasi-likelihood Regression within the Frame of the Accelerated Failure Time Model, Lili Yu, Karl E. Peace
Karl E. Peace

Spline Nonparametric Quasi-Likelihood Regression Within the Frame of the Accelerated Failure Time Model, Lili Yu, Karl E. Peace
Biostatistics Faculty Publications

Grant from C.A.R.E.S of Claxton, GA to Perform Public Health Research in Evans County, GA, Karl E. Peace, S. Charles
Karl E. Peace

The Professional Pharmaceutical Statisticians: Thinkers, Practitioners, and Leaders, Karl E. Peace, Kao-Tai Tsai
Karl E. Peace

Interval-Censored Time-to-Event Data: Methods and Applications, Ding-Geng Chen, Jianguo Sun, Karl E. Peace
Biostatistics Faculty Bookshelf

Bias and its Remedy in Interval Censored Time-to-Event Applications, Ding-Geng Chen, Lili Yu, Karl E. Peace, Jianguo Sun
Biostatistics Faculty Publications

Bias and its Remedy in Interval Censored Time-to-Event Applications, Ding-Geng Chen, Lili Yu, Karl E. Peace, Jianguo Sun
Karl E. Peace

Having Fun with Numbers!, Karl E. Peace
Karl E. Peace

Having Fun with Numbers!, Karl E. Peace
Karl E. Peace

Peace Honored with Regents’ Hall of Fame Award, Karl E. Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews

Marvin Zelen First Recipient of ASA Karl E. Peace Award for contributions toward betterment of Society, Karl E. Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews

Grant from Frontier Science and Technology (Marvin Zelen), Karl E. Peace
Karl E. Peace

2011

Clinical Trial Data Analysis Using R, Ding-Geng Chen, Karl E. Peace
Karl E. Peace

Case Study in Optimal Dosing in Duodenal Ulcer, Karl E. Peace
Biostatistics Faculty Publications

Clinically Optimal Dosing in the Treatment of Duodenal Ulcers: A Case Study of a Phase III SNDA Clinical Program, Karl E. Peace
Biostatistics Faculty Publications

PDF

Clinically Optimal Dosing in the Treatment of Duodenal Ulcers: A Case Study of a Phase III SNDA Clinical Program, Karl E. Peace
Karl E. Peace

MentalSquares − A Generic Bipolar Support Vector Machine for Mental Disorder Classification, Diagnostic Analysis, and Neurobiological Data Mining, Wen-Rang Zhang, Anand K. Pandurangi, Karl E. Peace, Yan-Qing Zhang
Karl E. Peace

MentalSquares − A Generic Bipolar Support Vector Machine for Mental Disorder Classification, Diagnostic Analysis, and Neurobiological Data Mining, Wen-Rang Zhang, Anand K. Pandurangi, Karl E. Peace, Yan-Qing Zhang
Biostatistics Faculty Publications

Grant from C.A.R.E.S of Claxton, GA to Perform Public Health Research in Evans County, GA, Karl E. Peace, S. Charles, S. Tedders
Karl E. Peace

Joint Modeling of Treatment Effect on Time-to-Event Endpoint and Safety Covariates in Control Clinical Trial Data Analysis, Kao-Tai Tsai, Karl E. Peace
Karl E. Peace

Genetic Matching: A Better Algorithm for Adjusting Covariate Imbalance for Statistical Data Analysis and Modeling, Karl E. Peace, Kao-Tai Tsai
Karl E. Peace

Genetic Matching: A Better Algorithm for Adjusting Covariate Imbalance for Statistical Data Analysis and Modeling, Kao-Tai Tsai, Karl E. Peace
Karl E. Peace

Joint Modeling of the Treatment Effect in Clinical Trials with Time-to-Event Endpoint and Safety Covariates, Kao-Tai Tsai, Karl E. Peace
Karl E. Peace

Joint Modeling of Treatment Effect on Time-to-Event Endpoint and Safety Covariates in Control Clinical Trial Data Analysis, Kao-Tai Tsai, Karl E. Peace
Karl E. Peace

Connecting Pharmaceutical Development to Public Health, Karl E. Peace
Karl E. Peace

Getting Funded: What Works and What Doesn’t, Karl E. Peace
Karl E. Peace

Genetic Matching: A Better Algorithm for Adjusting Covariate Imbalance for Statistical Data Analysis and Modeling, Kao-Tai Tsai, Karl E. Peace
Biostatistics Faculty Publications

Joint Modeling of the Treatment Effect in Clinical Trials with Time-to-Event Endpoint and Safety Covariates, Kao-Tai Tsai, Karl E. Peace
Biostatistics Faculty Publications

Case Study in Optimal Dosing in Duodenal Ulcer, Karl E. Peace
Karl E. Peace

Genetic Matching: A Better Algorithm for Adjusting Covariate Imbalance for Statistical Data Analysis and Modeling, Kao-Tai Tsai, Karl E. Peace
Karl E. Peace

Karl E. Peace – a Friend to the Biostatistics Community, Karl E. Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews

Master of Adversity: Overcoming long odds, Karl E. Peace was pivotal in JPHCOPH founding, Karl E. Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews

Bulloch County’s (no longer) Secret Advantage, Karl E. Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews

Karl Peace Honored with Painting, Karl E. Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews

2010

Interval-Censoring in Biomedical and Biopharmaceutical Clinical Trials, Ding-Geng Chen, Karl E. Peace, Lili Yu, Y. L. Lio, Yibin Wang
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Presentations

Clinical Trial Methodology, Karl E. Peace
Karl E. Peace

Grant from C.A.R.E.S of Claxton, GA to Perform Public Health Research in Evans County, GA, Karl E. Peace, K. Fitzmorris, S. Tedders
Karl E. Peace

Interval-Censoring in Biomedical and Biopharmaceutical Clinical Trials, Ding-Geng Chen, Karl E. Peace, Lili Yu, Y. L. Lio, Yibin Wang
Karl E. Peace

Interval-Censoring in Biomedical and Biopharmaceutical Clinical Trials, Ding-Geng Chen, Karl E. Peace, Lili Yu, Y. L. Lio, Yibin Wang
Biostatistics Faculty Publications

Interval-Censoring in Biomedical and Biopharmaceutical Clinical Trials, Ding-Geng Chen, Karl E. Peace, Lili Yu, Y. L. Lio, Yibin Wang
Karl E. Peace

Clinical Trial Methodology, Karl E. Peace, Ding-Geng Chen
Biostatistics Faculty Bookshelf

Clinical Trial Methodology, Karl E. Peace, Ding-Geng Chen
Karl E. Peace

Improve Membership in the APHA Statistics Section, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Contributions of Karl Peace recognized by the U.S. Congress, Karl E. Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews

Foreword by Karl E. Peace, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Sowing what you Reap, Karl E. Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews

Letter to the Editor, Re: Make a Plan and Follow it, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Clinical Trial Methodology, Karl E. Peace, Ding-Geng Chen
Karl E. Peace

Letter to the Editor, Re: Make a Plan and Follow it., Karl E. Peace
Karl E. Peace

Improve Membership in the APHA Statistics Section, Karl E. Peace
Karl E. Peace

2009

Analysis of Subgroup Data in Clinical Trials, Kao-Tai Tsai, Karl E. Peace
Biostatistics Faculty Presentations

PDF

Analysis of Subgroup Data in Clinical Trials, Karl E. Peace, Kao-Tai Tsai
Karl E. Peace

Grant from C.A.R.E.S of Claxton, GA to Perform Public Health Research in Evans County, GA, Karl E. Peace, K. Fitzmorris, S. Tedders
Karl E. Peace

Design and Analysis of Clinical Trials with Time to Event Endpoints, Karl E. Peace
Biostatistics Faculty Bookshelf

Overview of Parametric Based Inferential Methods for Time-to-Event Endpoints, Karl E. Peace, Kao-Tai Tsai
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Overview of Time-to-Event Endpoint Methodology, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Time-to-Event Endpoint Methods in Antibiotic Trials, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Monitoring Adverse Experiences in Clinical Drug Development, Karl E. Peace
Biostatistics Faculty Publications

Monitoring Adverse Experiences in Clinical Drug Development, Karl E. Peace
Karl E. Peace

Exploration of Developing a Clinical Trials Research Center, Karl E. Peace
Karl E. Peace

Paid In Full, Karl E. Peace
Biostatistics Faculty Bookshelf

Bivariate or Composite Plots of Endpoints, Karl E. Peace, Kao-Tai Tsai
Biostatistics Faculty Publications

Time-to-Event Endpoint Methods in Antibiotic Trials, Karl E. Peace
Karl E. Peace

Paid In Full, Karl E. Peace
Karl E. Peace

Multivariate Dose Response Test, Kao-Tai Tsai, Karl E. Peace
Biostatistics Faculty Publications

Design and Analysis of Clinical Trials with Time-to-Event Endpoints, Karl E. Peace
Karl E. Peace

Multivariate Dose Response Test, Kao-Tai Tsai, Karl E. Peace
Karl E. Peace

Overview of Time-to-Event Endpoint Methodology, Karl E. Peace
Karl E. Peace

Overview of Parametric based Inferential Methods for Time-to-Event Endpoints, Karl E. Peace
Karl E. Peace

Design and Analysis of Clinical Trials with Time to Event Endpoints, Karl E. Peace
Karl E. Peace

Bivariate or Composite Plots of Endpoints, Karl E. Peace, Kao-Tai Tsai
Karl E. Peace

2008

ASU Graduate Symposium to feature distinguished cancer scholar, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

ASU Graduate Symposium to feature distinguished cancer scholar, Karl E. Peace
Karl E. Peace

Improving Quality of Life at the Community Level, Karl E. Peace
Karl E. Peace

Grant from C.A.R.E.S of Claxton, GA to Perform Public Health Research in Evans County, GA, Karl E. Peace
Karl E. Peace

Dosing in the Elderly, Karl E. Peace
Karl E. Peace

On Truth, Uncertainity, Equilibrium and Harmony — A Taxonomy for YinYang Scientific Computing, Wen-Ran Zhang, Paul P. Wang, Karl E. Peace, Justin Zhan, Yan-Qing Yan-Qing Zhang
Department of Computer Science Faculty Publications

The Pharmaceutical Industry as a Major Player in Public Health, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

The Pharmaceutical Industry as a Major Player in Public Health, Karl E. Peace
Karl E. Peace

Safety of Drugs is, Indeed, a Lifecycle Exercise, Karl E. Peace
Biostatistics Faculty Publications

Safety of Drugs is, Indeed, a Lifecycle Exercise, Karl E. Peace
Karl E. Peace

Approval of Drugs in the USA, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Approval of Drugs in the USA, Karl E. Peace
Karl E. Peace

The Education of Clinical Trial Statisticians, Karl E. Peace
Karl E. Peace

Approval of Drugs in the US – Hitting close to Home, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

Approval of Drugs in the US – Hitting close to Home, Karl E. Peace
Karl E. Peace

Is Informed Consent as Ethical as It Could Be?, Karl E. Peace
Biostatistics Faculty Publications

Is Informed Consent as Ethical as It Could Be?, Karl E. Peace
Karl E. Peace

Commentary: Is Informed Consent as Ethical as it Could be?, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

The Education of Clinical Trial Statisticians, Karl E. Peace
Karl E. Peace

Interesting Pharmaceutical Clinical Trial Applications, Karl E. Peace
Karl E. Peace

On Truth, Uncertainty, Equilibrium and Harmony — A Taxonomy for YinYang Scientific Computing, Wen-Ran Zhang, Paul P. Wang, Karl E. Peace, Justin Zhan, Yan-Qing Zhang
Karl E. Peace

Assessing the Validity of Statistical Inferences in Public Health Research: An Evidence-Based, "Best Practices" Approach, Karl E. Peace, Anthony V. Parrillo, Charlie J. Hardy
Biostatistics Faculty Publications

Assessing the Validity of Statistical Inferences in Public Health Research: An Evidence-Based, "Best Practices" Approach, Karl E. Peace, Anthony V. Parrillo, Charlie J. Hardy
Karl E. Peace

2007

Community Health Assessment Grant from Phoebe-Putney Hospital in Albany, Georgia, Karl E. Peace, C. J. Hardy
Karl E. Peace

Does Public Health Matter?, Charles J. Hardy, Karl E. Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews

Every Person must Decide, Karl E. Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews

Summarization and Analysis of Pharmaceutical Safety Data, Karl E. Peace
Karl E. Peace

Assessment of Drug Safety, Karl E. Peace
Biostatistics Faculty Publications

Yin Yang Mental Squares - An Equilibrium-Based System for Bipolar Neurobiological Pattern Classification and Analysis, Wen-Ran Zhang, Karl E. Peace
Biostatistics Faculty Publications

Yin Yang Mental Squares - An Equilibrium-Based System for Bipolar Neurobiological Pattern Classification and Analysis, Wen-Rang Zhang, Karl E. Peace
Karl E. Peace

The Man from Alligator Creek, Karl E. Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews

YinYang Dynamic Neurobioological Modeling and Diagnostic Analysis of Major Depressive and Bipolar Disorders, Wen-Rang Zhang, Anand K. Pandurangi, Karl E. Peace
Biostatistics Faculty Publications

YinYang Dynamic Neurobioological Modeling and Diagnostic Analysis of Major Depressive and Bipolar Disorders, Wen-Ran Zhang, Anand K. Pandurangi, Karl E. Peace
Karl E. Peace

Multivariate Dose-Response Analysis of Ordinal Response Data, Kao-Tai Tsai, Karl E. Peace
Biostatistics Faculty Publications

Incubating the ICSA Central Office Within the Jiann-Ping Hsu College of Public Health, Karl E. Peace
Karl E. Peace

Statistical and Regulatory Sciences Invited Session, Karl E. Peace
Karl E. Peace

Toward a New Standard for Classification and Analysis of Bipolar Disorders with Mixed States, Wen-Rang Zhang, Karl E. Peace, A. K. Pandurangi
Karl E. Peace

Toward a New Standard for Classification and Analysis of Bipolar Disorders with Mixed States, Wen-Rang Zhang, Karl E. Peace, Anand K. Pandurangi
Biostatistics Faculty Publications

A Survival Analysis Instead of an Endpoint Analysis for Antibiotic Data, Karl E. Peace
Biostatistics Faculty Publications

The Design and Analysis of Pivotal Proof of Efficacy Trials in the Development of Drugs to Treat Panic Disorder, Karl E. Peace
Biostatistics Faculty Publications

Toward a New Standard for Classification and Analysis of Bipolar Disorders with Mixed States, Wen-Rang Zhang, Karl E. Peace, Anand K. Pandurangi
Karl E. Peace

Ten Commandments of Good Health, Anthony V. Parrillo, K. Chester, Karl E. Peace
Karl E. Peace

Using Primary Care Practices to Increase Cancer Information Access in Rural Settings, Karl E. Peace, A. V. Parillo, D. Ballard, B. S. Davidson, C. Marshall, R. C. Vanderpool
Karl E. Peace

Center for Biostatistics Grant, Karl E. Peace
Karl E. Peace

Kings of the road: A driving passion for classic car collectors, Karl E. Peace
Department of Biostatistics, Epidemiology and Environmental Health Sciences Faculty Media Appearances and Interviews

A Survival Analysis Instead of an Endpoint Analysis for Antibiotic Data, Karl E. Peace
Karl E. Peace

The Design and Analysis of Pivotal Proof of Efficacy Trials in the Development of Drugs to Treat Panic Disorder, Karl E. Peace
Karl E. Peace

2006

Adaptive Selection of Counties to Control Versus Intervention Groups in SW Georgia Behavioral Study, Karl E. Peace
Biostatistics Faculty Publications

Adaptive Selection of Counties to Control versus Intervention Groups in SW Georgia Behavioral Study, Karl E. Peace, James A. Hotz, Diane M. Fletcher, Denise Ballad, Charles J. Hardy
Karl E. Peace

Equilibrium-Based Bipolar Neurological Modeling, Wen-Rang Zhang, Anand K. Pandurangi, Karl E. Peace
Karl E. Peace

Equilibrium-Based Bipolar Neurological Modeling, Wen-Ran Zhang, Anand K. Pandurangi, Karl E. Peace
Biostatistics Faculty Publications

Equilibrium-Based Bipolar Neurological Modeling, Wen-Rang Zhang, Anand K. Pandurangi, Karl E. Peace
Karl E. Peace

Screening for Cancer in Baker County, Georgia, Karl E. Peace
Karl E. Peace

Fixed Combination Drug Development and the Need for Placebo, Karl E. Peace
Biostatistics Faculty Publications

The Validity of Statistical Inference, Karl E. Peace
Biostatistics Faculty Publications

Racial Differences in Perception of Breast Cancer Risk in Rural Southeast Georgia, Stuart Tedders, Anthony V. Parrillo, Karl E. Peace, Jannell R. Knight
Biostatistics Faculty Publications

Biostatistical Aspects of the Development of Drugs to Prevent NSAID Induced Gastric Ulcers, Karl E. Peace
Biostatistics Faculty Publications

Clinical Trials: Location Matters, Karl E. Peace
Biostatistics Faculty Publications

Statistical Analysis Methods for Providing Inferences between Primary Response Measures and Exposure to Study Medication, Karl E. Peace, H. C. Carter
Biostatistics Faculty Publications

Public Health Classroom, J. Grillo, Karl E. Peace
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

The Importance of the Question Relative to Statistical Analysis in Medical Research, Karl E. Peace
Biostatistics Faculty Publications

Sample Sizes in the Clinical Development Plan Premarket Approval, Karl E. Peace
Biostatistics Faculty Publications

Sample Sizes in the Clinical Development Plan Premarket Approval, Karl E. Peace
Karl E. Peace

Statistical Analysis Methods for Providing Inferences between Primary Response Measures and Exposure to Study Medication, Karl E. Peace, H. C. Carter
Karl E. Peace

Racial Differences in Perception of Breast Cancer Risk in Rural Southeast Georgia, Stuart H. Tedders, Anthony V. Parrillo, Karl E. Peace, Jannell R. Knight
Karl E. Peace

Clinical Trials: Location Matters, Karl E. Peace
Karl E. Peace

Biostatistical Aspects of the Development of Drugs to Prevent NSAID Induced Gastric Ulcers, Karl E. Peace
Karl E. Peace

The Importance of the Question Relative to Statistical Analysis in Medical Research, Karl E. Peace
Karl E. Peace

The Validity of Statistical Inference, Karl E. Peace
Karl E. Peace

Public Health Classroom, J. Grillo, Karl E. Peace
Karl E. Peace

Fixed Combination Drug Development and the Need for Placebo, Karl E. Peace
Karl E. Peace

2005

On Some Statistical Issues Involving Clinical Trials in Oncology, Karl E. Peace, M. Rothman
Biostatistics Faculty Presentations

Utilization of Bivariate Plots in Clinical Trials with Two Primary Endpoints, Karl E. Peace
Karl E. Peace

Sample Sizes in the Clinical Development Program, Karl E. Peace
Karl E. Peace

Overview of Clinical Trial Research, Karl E. Peace
Karl E. Peace

Some Old Regulatory Issues Revisited: Use of Chebyshev’s Inequality in Decisions Regarding Bioequivalence, One-Sided Rather Than Two-Side P-Values in Placebo Controlled Trials, The Need for Placebo in Combination Trials, Karl E. Peace
Karl E. Peace

Overview of Clinical Research at the Community Level, Karl E. Peace
Karl E. Peace

Biopharmaceutical and Regulatory Sciences Session, Karl E. Peace
Karl E. Peace

The Statistical Section of a Clinical Protocol, Karl E. Peace
Biostatistics Faculty Publications

Making Informed Consent More Ethical, Karl E. Peace
Biostatistics Faculty Publications

On the Analysis of a Combination of Two Primary Efficacy Measures, Karl E. Peace
Biostatistics Faculty Publications

The Statistical Section of a Clinical Protocol, Karl E. Peace
Karl E. Peace

On the Analysis of a Combination of Two Primary Efficacy Measures, Karl E. Peace
Karl E. Peace

Making Informed Consent More Ethical, Karl E. Peace
Karl E. Peace

2004

Biostatistical Aspects of Clinical Drug Development, the Basic Components of a Protocol, and the Statistical Analysis Section of a Protocol, Karl E. Peace
Karl E. Peace

Biostatistical Aspects of the Development of Anti-Ulcer Drugs, Anti-Anginal Drugs and Drugs for the Treatment of Alzheimer’s Disease, Karl E. Peace
Karl E. Peace

The Statistical Analysis of Dose Response Experiments, Karl E. Peace
Karl E. Peace

Structure of a World Class Clinical Research Program, Karl E. Peace
Karl E. Peace

Tribute to a Life of Quality: Memorial to Dr. Jiann-Ping Hsu, Karl E. Peace
Karl E. Peace

Re (Assessing) the Co-Administration of Steroids and Antibiotics in Metastatic Brain Cancer Patients, Karl E. Peace
Karl E. Peace

Exposure Analyses of Dichotomous Endpoints in Long-Term Cardiovascular Trials, Karl E. Peace
Karl E. Peace

The History of the Biopharmaceutical Section of the American Statistical Association, R. L. Davis, S. M. Free, S. W. Gulyas, M. S. Hearron, S. R. Lindborg, R. T. O'Neill, C. B. Sampson, Karl E. Peace
Karl E. Peace

2003

Interesting and Unusual Applications from 30 Years of Biostatistical Consulting, Karl E. Peace
Karl E. Peace

Clinical Trial Methodology and Biostatistics, Karl E. Peace
Karl E. Peace

On the Need for Placebo in Combination Drug Development, Karl E. Peace
Karl E. Peace

2002

Clinical Trials and Biostatistics, Karl E. Peace
Karl E. Peace

Distinguished Cancer Scholar, Karl E. Peace
Karl E. Peace

Report of a Workshop on Confirmatory Evidence to Support a Single Clinical Trial as a Basis for New Drug Approval, Carl C. Peck, Jill Wechsler, Karl E. Peace
Karl E. Peace

Biostatistical Aspects of Clinical Research Programs, Karl E. Peace
Karl E. Peace

The Importance of Numbers of Patients in Cancer Clinical Trials, Karl E. Peace
Karl E. Peace

Clinical Trial Methodology, Karl E. Peace
Karl E. Peace

One Versus Two ASCCT: New Paradigm for Efficacy, Karl E. Peace
Karl E. Peace

2001

GSU and the Georgia Research Alliance, Karl E. Peace
Karl E. Peace

The Importance of Numbers of Patients in Clinical Trials, Karl E. Peace
Karl E. Peace

Biopharmaceutical Statistics in a Pharmaceutical Regulated Environment: Past, Present and Future, Karl E. Peace, Anthony C. Segreti, Hoi M. Leung, Gary G. Koch, Robert L. Davis, Noel R. Mohberg
Karl E. Peace

1998

Journal of Biopharmaceutical Statistics, Karl E. Peace
Karl E. Peace

1996

Directional Decision for a Two-Tailed Alternative, Karl E. Peace
Karl E. Peace

1995

Differential Efficacy of High Dose Tacrine in Alzheimer's Disease, Karl E. Peace
Karl E. Peace

Alternative Methods for Analyzing Clinical Trials in Panic Disorder, Karl E. Peace
Karl E. Peace

The Use of Survival Analysis Techniques to Determine the Effect of Long-Term, Open-Label Tacrine Treatment on Nursing Home Placement and Mortality, Karl E. Peace
Karl E. Peace

Some Statistical Issues in Pharmaceutical Applications, Karl E. Peace
Karl E. Peace

Training of Statisticians for Government and Pharmaceutical Industry, Karl E. Peace
Karl E. Peace

Considerations Concerning Subpopulations in the Clinical Development of New Drugs, Karl E. Peace
Karl E. Peace

To Pool or Not, Karl E. Peace
Karl E. Peace

1994

Biopharmaceutical Sequential Statistical Applications, Karl E. Peace
Karl E. Peace

Drug Development Strategies for Subpopulations, Karl E. Peace
Karl E. Peace

To Pool or Not (To Pool), Karl E. Peace
Karl E. Peace

The Effect of Tacrine and Lecithin in Alzheimer's Disease: A Population Pharmacodynamic Analysis of Five Clinical Trials, Karl E. Peace, N. H. G. Holford
Karl E. Peace

1993

Enrichment Studies in Alzheimer's Disease: Design, Analysis and Interpretation Issues, Karl E. Peace
Karl E. Peace

Population Pharmacodynamic Model Analysis in the Study of Tacrine in Alzheimer's Disease, Karl E. Peace
Karl E. Peace

Issues in Bioequivalence Studies: A Review of the FDA Guidance on Statistical Procedures, Karl E. Peace
Karl E. Peace

Discussion for Interim Analyses and Sample Size Reestimation, Karl E. Peace
Karl E. Peace

Statistical Issues in the Design and Analysis of Ulcer Healing and Recurrence Studies, Gary G. Koch, Ingrid A. Amara, John Forster, David McSorley, Karl E. Peace
Karl E. Peace

Exposure Analysis of Time-to-Event Data in the Primary Helsinki Heart Study, Karl E. Peace
Karl E. Peace

Design and Analysis Considerations for Safety Data, Particularly Adverse Events, Karl E. Peace
Karl E. Peace

Linear Models Analysis of Primary Efficacy Data in the Study of Tacrine in Alzheimer's Disease, Karl E. Peace
Karl E. Peace

Statistical Methods for a Three-Period Crossover Design in Which High Dose Cannot be Used First, Karl E. Peace, Gary G. Koch
Karl E. Peace

Exposure Analysis of Dichotomous Response Measures in Long-Term Studies, Karl E. Peace, W. Hans Carter Jr.
Karl E. Peace

1992

Methodologic Aspects of a Population Pharmacodynamic Model for Cognitive Effects in Alzheimer's patients Treated with Tacrine, N. H. G. Holford, Karl E. Peace
Karl E. Peace

Results and Validation of a Population Pharmacodynamic Model for Cognitive Effects in Alzheimer's Patients Treated with Tacrine, N. H. G. Holford, Karl E. Peace
Karl E. Peace

Statistical Approaches to Two Real Problems, Karl E. Peace
Karl E. Peace

Design and Analysis of Bioavailability/Bioequivalence Studies, Karl E. Peace
Karl E. Peace

Sample Size Considerations in Clinical Development, Karl E. Peace
Karl E. Peace

Statistical Methods for a Three Period Crossover Design in Which High Dose Can’t Be Used First, Karl E. Peace
Karl E. Peace

On the Analysis of a Combination of Two Primary Efficacy Measures, Karl E. Peace
Karl E. Peace

Biopharmaceutical Statistical Applications, Karl E. Peace
Karl E. Peace

The Impact of Investigator Heterogeneity in Clinical Trials on Detecting Treatment Difference, Karl E. Peace
Karl E. Peace

Exposure Analysis of Time-to-Event Data in the Ancillary Helsinki Heart Study, Karl E. Peace
Karl E. Peace

Interim Analyses and Sample Size Re-Estimation, Karl E. Peace
Karl E. Peace

Statistical Analysis of a Three-Period Crossover Design in Which High Dose Can't Be Used First, Karl E. Peace
Karl E. Peace

Biopharmaceutical Sequential Statistical Applications, Karl E. Peace
Karl E. Peace

Early Termination of Two Trials of Misoprostol in the Prevention of NSAID induced Gastric Ulceration, Karl E. Peace
Karl E. Peace

An Ethical Issue Concerning Informed Consent in Clinical Trials, Karl E. Peace
Karl E. Peace

1991

Bioequivalence Testing, Karl E. Peace
Karl E. Peace

Interim Analysis of Duodenal and Gastric Ulcer Trials, Karl E. Peace
Karl E. Peace

Statistical Aspects of Dose Proportionality Studies, Karl E. Peace
Karl E. Peace

Clinical Trials in the Preventions of NSAID induced Gastric Ulceration, Karl E. Peace
Karl E. Peace

Exposure Analysis of Dichotomous Data, Karl E. Peace
Karl E. Peace

Pharmacodynamic Model of Alzheimer's Disease Progression, Karl E. Peace
Karl E. Peace

Sample Size Considerations in Clinical Trials Premarket Approval, Karl E. Peace
Karl E. Peace

Statistical Aspects of Clinical Research, Karl E. Peace
Karl E. Peace

Meta-Analysis in Ulcer Disease, Karl E. Peace
Karl E. Peace

Biostatistical Considerations in Studies in Special Populations, Karl E. Peace
Karl E. Peace

Exposure Analysis of Critical Event Data from the Ancillary Helsinki Heart Study, Karl E. Peace
Karl E. Peace

The Impact of Investigator Heterogeneity in Clinical Trials on Detecting Treatment Differences, Karl E. Peace
Karl E. Peace

Assessment of Bioequivalence Using a Multiplicative Model, Shein-Chung Chow, Karl E. Peace, Jun Shao
Karl E. Peace

One-Sided or Two-Sided ρ-Values: Which Most Appropriately Address the Question of Drug Efficacy?, Karl E. Peace
Karl E. Peace

Shortening the Time for Clinical Drug Development, Karl E. Peace
Karl E. Peace

1990

Statistical Issues in Drug Research and Development (2-Day Short Course), Karl E. Peace
Karl E. Peace

Biopharmaceutical Statistics for Drug Development (Week Long Short Course), Karl E. Peace
Karl E. Peace

Statistical Aspects of Clinical Research Programs (Week Long Short Course), Karl E. Peace
Karl E. Peace

Pharmaceutical Industrial Statistics (Week Long Short Course), Karl E. Peace
Karl E. Peace

One-Sided and Two-Sided Tests, Karl E. Peace
Karl E. Peace

Shortening the Time for Clinical Development, Karl E. Peace
Karl E. Peace

Decision Rules for Bioequivalence Studies, Karl E. Peace
Karl E. Peace

TMO: The Trial Management Organization—A New System for Reducing the Time for Clinical Trials, Karl E. Peace
Karl E. Peace

File Drawers, P-Values and Efficacy of Drugs – Response, Karl E. Peace
Karl E. Peace

Rejoinder to Comments on "The Alternative Hypothesis: One-Sided or Two-Sided?", Karl E. Peace
Karl E. Peace

1989

Issues in Bioequivalence Testing, Karl E. Peace
Karl E. Peace

Analysis of Ratios in Bioequivalence Testing, Karl E. Peace
Karl E. Peace

Dual Control Groups in Animal Carcinogenicity Studies, J. K. Haseman, G. Hajian, K. S. Crump, M. R. Selwyn, Karl E. Peace
Karl E. Peace

Considerations in Combination Drug Development, Karl E. Peace
Karl E. Peace

Statistical Issues in Pharmaceutical Drug Development, Karl E. Peace
Karl E. Peace

Design, Monitoring and Other Analysis Issues, Karl E. Peace
Karl E. Peace

ASA Biopharmaceutical Section Work Groups, Karl E. Peace
Karl E. Peace

The Use of Response Surface Methodology in the Development of Anti-Anginal Drugs, Karl E. Peace
Karl E. Peace

Analysis of Ratios in Bioequivalence Testing, Karl E. Peace
Karl E. Peace

The Importance of Numbers in Clinical Research, Karl E. Peace
Karl E. Peace

Some Thoughts on the Biopharmaceutical Section and Statistics, Karl E. Peace
Karl E. Peace

Statistical Considerations in Medical Device Development, Karl E. Peace
Karl E. Peace

Decision Rules for Bioequivalence Studies, Karl E. Peace
Karl E. Peace

The Analysis of Clinical Safety Data, Karl E. Peace
Karl E. Peace

Bioequivalence and the Balaam Design, Karl E. Peace
Karl E. Peace

Determining the Optimal Dosage Regimen for H2-Receptor Antagonist Therapy—A Dose Validation Approach, M. D. Young, William O. Frank, Brian Dickson, Karl E. Peace, Alan Braverman, W. Mounce
Karl E. Peace

The Alternative Hypothesis: One-Sided or Two-Sided?, Karl E. Peace
Karl E. Peace

Intention to Treat in Clinical Trials, L. D. Fisher, D. O. Dixon, J. Herson, R. K. Frankowski, M. S. Hearron, Karl E. Peace
Karl E. Peace

The Two-Treatment, Two-Period, Four-Sequence Design, Karl E. Peace
Karl E. Peace

1988

Biotechnology and the Biostatistician, Karl E. Peace, Thomas D. Cannon
Karl E. Peace

The Assessment of Bioequivalence (Short Course), Karl E. Peace
Karl E. Peace

Cost Benefit Assessment of Pharmaceutical Products, Karl E. Peace
Karl E. Peace

Cost Benefit Assessment of Misoprostol to Cimetidine in the Treatment of Peptic Ulcer Disease, Frank Lanza, Karl E. Peace, Harvey Zimmerman, Brian Dickson
Karl E. Peace

The Treatment of Gastric Ulcer with Antisecretory Drugs: Relationship of Pharmacological Effect to Healing Rates, C. W. Howden, D. B. Jones, Karl E. Peace, D. W. Burget, R. H. Hunt
Karl E. Peace

The Analysis of Clinical Safety Data, Karl E. Peace
Karl E. Peace

A Blinded Endoscopic Comparative Study of Misoprostol vs. Sucralfate and Placebo in the Prevention of Aspirin Induced Gastric and Duodenal Ulceration, Karl E. Peace, F. Lanza, L. Gustitus, M. F. Rack, Brian Dickson
Karl E. Peace

Comparison of Equal-Weight Oral Dosages of Verapamil Hydrochloride and Diltiazem Hydrochloride in Patients with Mild to Moderate Hypertension, J. W. Hollifield, J. J. Heusner, M. DesChamps, J. Gray, D. A. Spyker, Karl E. Peace, Brian Dickson
Karl E. Peace

Some Thoughts on One-Sided Tests, Karl E. Peace
Karl E. Peace

The Effect of Initial Treatment for Duodenal Ulcer on Subsequent Relapse Rates, R. Hunt, S. Chiverton, D. W. Burgett, Karl E. Peace, Brian Dickson
Karl E. Peace

Some Thoughts on One-Tailed Tests, Karl E. Peace
Karl E. Peace

Biotechnology and the Biostatistician, Karl E. Peace
Karl E. Peace

Assessment of Pharmacological Activity, J. J. Hubert, N. R. Bohidar, Karl E. Peace
Karl E. Peace

Pharmaceutical Formulation Development, N. R. Bohidar, Karl E. Peace
Karl E. Peace

Biopharmaceutical Statistics in Drug Development, Karl E. Peace
Karl E. Peace

Cost-Effectiveness in Treatment of Peptic Ulcer Disease, Karl E. Peace, Harvey Zimmerman
Karl E. Peace

1987

Matched Pair Designs in Controlling Confounding Factors in D.U. Recurrence, Karl E. Peace
Karl E. Peace

Definitive Study Design in Assessing the Effectiveness of Misoprostol in the Treatment and Prevention of NSAID Gastric Ulceration, Karl E. Peace
Karl E. Peace

Spontaneous D.U. Recurrence: The Case of Misoprostol and Cimetidine, Karl E. Peace
Karl E. Peace

The Effectiveness of Misoprostol in Preventing NSAID Gastric Ulceration, Karl E. Peace
Karl E. Peace

PMA Biostatistics Subsection Report, Karl E. Peace
Karl E. Peace

PMA Biostatistics Subsection Report, Karl E. Peace
Karl E. Peace

Life Table Meta-Analysis of Spontaneous Duodenal Ulcer Relapse Data, Karl E. Peace
Karl E. Peace

Use of Response Surface Methods in Determining Dose and Frequency in the Development of Anti-Ulcer Drugs, Karl E. Peace
Karl E. Peace

The Effect of Acute Treatment with Misoprostol (MIS), Cimetidine (CIM) and Placebo on Spontaneous Duodenal Ulcer Relapse, Brian Dickson, Karl E. Peace
Karl E. Peace

Design, Monitoring, and Analysis Issues Relative to Adverse Events, Karl E. Peace
Karl E. Peace

P-Values and Power Computations in Multiple Look Trials, Karl E. Peace, Robert C. Schriver
Karl E. Peace

Evaluatable versus Evaluable: A Post-Script, Karl E. Peace
Karl E. Peace

Effect of Cimetidine 800 mg h.s. and 300 mg q.i.d. on the Pharmaceutics of Warfarin in Patients Receiving Maintenance Warfarin Therapy, M. J. Sax, W. Randolph, Karl E. Peace, S. Chretian, William O. Frank, D. R. Gray, L. McCree, Alan Braveman, F. Wyle, B. J. Jackson, M. Beg
Karl E. Peace

Meta-analysis of DU Relapse using actual Patient Data: A comparison of the Effect of Acute Treatment with Cimetidine, Misoprostol and Placebo, Karl E. Peace
Karl E. Peace

Meta-analysis of DU Relapse using actual Patient Data: A comparison of the Effect of Acute Treatment with Cimetidine, Misoprostol and Placebo, Karl E. Peace
Karl E. Peace

An Analysis of GD Searle in-house data on Spontaneous DU Recurrence, Karl E. Peace
Karl E. Peace

Matched Pair Designs in Controlling Confounding Factors in D.U. Recurrence, Karl E. Peace, B. Dickson
Karl E. Peace

The Effect of Acute Treatment with Misoprostol, Cimetidine and Placebo on Spontaneous Duodenal Ulcer Relapse, Karl E. Peace
Karl E. Peace

A Single Blind Comparative Study of Misoprostol to Sucralfate and Placebo in the Prevention of Aspirin Induced Ulceration, F. Lanza, Karl E. Peace, L. Gustitus
Karl E. Peace

Determining the Optimal Dosage Regimen for H2-receptor Antagonist Therapy – a dose validation approach, M. D. Young, William O. Frank, Brian Dickson, Karl E. Peace, Alan Braveman, W. Mounce
Karl E. Peace

An Analysis of GD Searle in-house data on Spontaneous DU Recurrence, Karl E. Peace
Karl E. Peace

1986

The Effect of Single I.V. Doses of Cimetidine or Ranitidine on Gastric Secretion, William O. Frank, Karl E. Peace
Karl E. Peace

The Effect of Age on Theophylline Steady-State Serum Levels and Clearance in Normal Subjects, W. C. Randolph, John J. Seaman, Brian Dickson, Karl E. Peace, William O. Frank, M. D. Young
Karl E. Peace

Analysis of Ratios in Bioequivalency Testing, Karl E. Peace
Karl E. Peace

Estimating the Degree of Equivalence or Non-Equivalence: An Alternative to Bioequivalency Testing, Karl E. Peace
Karl E. Peace

Discussion of the Statistical and Clinical Guidelines for the Content and Format of an Application, Karl E. Peace
Karl E. Peace

Equiradial Hexagonal RSM Designs: An Application to Anti-Anginal Drug Development, Karl E. Peace
Karl E. Peace

Ideal Protocol Development for New Anti-Ulcer Drugs, Karl E. Peace
Karl E. Peace

Bioequivalence of a new 800 mg Cimetidine Tablet with Commercially Available 400 mg Tablets, W. C. Randolph, Karl E. Peace, John J. Seaman, Brian Dickson, K. Putterman
Karl E. Peace

Age-Related Differences in Theophylline Clearance at Steady State, W. C. Randolph, Karl E. Peace, W. D. Franke, John J. Seaman
Karl E. Peace

Estimating the Degree of Equivalence or Non-Equivalence – An Alternative to Bioequivalency Testing, Karl E. Peace
Karl E. Peace

Serum Theophylline Levels, John J. Seaman, W. C. Randolph, Karl E. Peace, W. O. Frank, B. Dickson, K. Putterman, M. D. Young
Karl E. Peace

Age-Related Differences in Theophylline Clearance at Steady State, Karl E. Peace, W. C. Randolph, William O. Frank, John J. Seaman
Karl E. Peace

1985

Design, Monitoring and Analysis Issues Relative to Adverse Events, Karl E. Peace
Karl E. Peace

Issues in the Use of Two Identical Controls in Carcinogenicity Studies, Karl E. Peace
Karl E. Peace

Drug Receptor Theory Statistical Methodology, Karl E. Peace
Karl E. Peace

ASA Biopharmaceutical Section Work Group Efforts, Karl E. Peace
Karl E. Peace

Statistical Considerations in the Design, Analysis and Interpretation of Single-Dose, Active Duodenal Ulcer Trials; Cimetidine, Karl E. Peace
Karl E. Peace

Report on Biopharmaceutical Section Work Group Activity, Karl E. Peace
Karl E. Peace

Design, Analysis and Interpretation of Oncology Trials, Karl E. Peace
Karl E. Peace

Statistical Considerations in Protocol Development, Karl E. Peace
Karl E. Peace

A Single Nocturnal Dose of Cimetidine in Active Duodenal Ulcer: Result of a United States Multicenter Trial, Karl E. Peace, Brian Dickson, W. Dixon, K. Putterman, M. D. Young
Karl E. Peace

Effects of Two Cimetidine Dosage Regimens on Serum Theophylline Levels, John J. Seaman, W. Randolph, Karl E. Peace, William O. Frank, Brian Dickson, K. Putterman, M. D. Young
Karl E. Peace

Evaluatable vs. Evaluable, Karl E. Peace
Karl E. Peace

Efficacy of a Single Nocturnal Dose of Cimetidine in Active Duodenal Ulcer: Result of a United States Multicenter Trial, J. Venezuela, B. Dickson, W. Dixon, Karl E. Peace, K. Putterman, M. D. Young
Karl E. Peace

Cimetidine Single-Dose Active Duodenal Ulcer Protocol Design, Brian Dickson, W. Dixon, Karl E. Peace, K. Putterman, M. D. Young
Karl E. Peace

1984

Evaluatable, Not Evaluable, Karl E. Peace
Karl E. Peace

Report on ASA Biopharmaceutical Section Work Group Coordinator, Karl E. Peace
Karl E. Peace

Report on ASA Biopharmaceutical Section Work Group Coordinator, Karl E. Peace
Karl E. Peace

Degrees of Freedom in a Nonparametric Test, Karl E. Peace
Karl E. Peace

Data Listings Should Reflect Experimental Structure, Karl E. Peace
Karl E. Peace

Evaluable or Evaluatable?, Karl E. Peace
Karl E. Peace

1983

A Two-Day Workshop on Statistical Aspects of Clinical Research, Karl E. Peace
Karl E. Peace

The Dose Comparison Trial, Karl E. Peace
Karl E. Peace

Lidocaine-Cimetidine Interaction, William O. Frank, John J. Seaman, Karl E. Peace, R. M. Myerson, T. J. Humphries
Karl E. Peace

A Critique of the Grizzle, Balaam and White Designs, Karl E. Peace
Karl E. Peace

Group Sequential Analysis of Survival Data, Karl E. Peace
Karl E. Peace

Biostatistics Clinical Trials Workshop, Karl E. Peace
Karl E. Peace

Minimally Effective Dose of Guanfacine For Treatment of Mild to Moderate Hypertension, S. A. Tisdale, Karl E. Peace, P. P. Mathur, S. L. Hutcherson
Karl E. Peace

1981

A Note Concerning Carr's Extension of Fisher's Exact Test to More than Two Samples of Equal Size, R. M. Brugger, E. C. Cramer, J. J. Gart, S. L. George, J. G. Karas, L. M. Hsu, Karl E. Peace, A. Verbeck, P. M. Kroonenberg
Karl E. Peace

An Evaluation of Triprolidine and Pseudoephedrine in the Treatment of Allergic Rhinitis, L. Diamond, K. Gerson, A. Cato, Karl E. Peace, J. G. Perkins
Karl E. Peace

1979

Performing a Survival Analysis Instead of an Endpoint Analysis, Karl E. Peace
Karl E. Peace

Performing a Survival Analysis Instead of an Endpoint Analysis, Karl E. Peace
Karl E. Peace

Performing a Survival Analysis Instead of an Endpoint Analysis, Karl E. Peace
Karl E. Peace

1978

Size and Power Assessment of Tests of Hypotheses on Survival Parameters, Karl E. Peace, Roger E. Flora
Karl E. Peace

1977

Effect of Antilymphocyte Globulin Potency on Survival of Cadaver Renal Transplants, F. Thomas, J. Thomas, R. Flora, G. Mendez-Picon, Karl E. Peace, H. M. Lee
Karl E. Peace

Stochastic Processes and Markov Chains with Applications, Karl E. Peace
Karl E. Peace

Introductory Probability Theory and Statistical Inference, Karl E. Peace
Karl E. Peace

1976

Analysis of Categorical Data: a) A Survival Analysis Instead of an Endpoint Analysis in a Parallel Design; b) Within a Crossover Design, Karl E. Peace
Karl E. Peace

Efficiency Assessments and Tests of Hypotheses on Survival Parameters, Karl E. Peace
Karl E. Peace

Some Results in the Estimation of Survival Parameters, Karl E. Peace
Karl E. Peace

Hypocalcemia and Parathyroid Hormone in Pancreatitis, Giles M. Robertson, Karl E. Peace
Karl E. Peace